Wegovy is a GLP-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with comorbidities, whilst lisdexamfetamine is a central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD)
In a Treg Cd226 conditional knockout model, female NOD mice also displayed decreased insulitis and diabetes incidence, supporting the notion that CD226 is involved in Treg stability (95)
This is important in laboratory studies, as LPS can interfere with experimental outcomes and immune-response measurements in research models
Fine particulate matter triggers alpha-synuclein fibrillization and Parkinson-like neurodegeneration
The healthcare industry is at its best when innovation, safety, and patient access work together
You can also browse our Immunity Supplements collection for more options in this category